Last updated on September 2018

A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia


Brief description of study

The objective of this study is to evaluate the efficacy and the safety when ASP1517 is intermittently administered in Erythropoiesis Stimulating Agent (ESA)-untreated non-dialysis chronic kidney disease patients with anemia.

Clinical Study Identifier: NCT02964936

Contact Investigators or Research Sites near you

Start Over

Astellas Pharma Inc.

Site JP00007
Aichi, Japan

Astellas Pharma Inc.

Site JP00018
Aichi, Japan

Astellas Pharma Inc.

Site JP00028
Aichi, Japan

Astellas Pharma Inc.

Site JP00001
Chiba, Japan

Astellas Pharma Inc.

Site JP00035
Ehime, Japan

Astellas Pharma Inc.

Site JP00012
Fukui, Japan

Astellas Pharma Inc.

Site JP00011
Fukuoka, Japan

Astellas Pharma Inc.

Site JP00031
Fukuoka, Japan

Astellas Pharma Inc.

Site JP00030
Hiroshima, Japan

Astellas Pharma Inc.

Site JP00034
Hiroshima, Japan

Astellas Pharma Inc.

Site JP00036
Hiroshima, Japan

Astellas Pharma Inc.

Site JP00005
Hokkaido, Japan

Astellas Pharma Inc.

Site JP00020
Hyogo, Japan

Astellas Pharma Inc.

Site JP00015
Ibaraki, Japan

Astellas Pharma Inc.

Site JP00017
Ibaraki, Japan

Astellas Pharma Inc.

Site JP00021
Ibaraki, Japan

Astellas Pharma Inc.

Site JP00025
Ibaraki, Japan

Astellas Pharma Inc.

Site JP00037
Ibaraki, Japan

Astellas Pharma Inc.

Site JP00033
Ishikawa, Japan

Astellas Pharma Inc.

Site JP00029
Iwate, Japan

Astellas Pharma Inc.

Site JP00006
Kanagawa, Japan

Astellas Pharma Inc.

Site JP00014
Kanagawa, Japan

Astellas Pharma Inc.

Site JP00038
Kanagawa, Japan

Astellas Pharma Inc.

Site JP00010
Miyagi, Japan

Astellas Pharma Inc.

Site JP00016
Nagano, Japan

Astellas Pharma Inc.

Site JP00024
Niigata, Japan

Astellas Pharma Inc.

Site JP00032
Oita, Japan

Astellas Pharma Inc.

Site JP00003
Osaka, Japan

Astellas Pharma Inc.

Site JP00009
Osaka, Japan

Astellas Pharma Inc.

Site JP00026
Osaka, Japan

Astellas Pharma Inc.

Site JP00002
Saitama, Japan

Astellas Pharma Inc.

Site JP00019
Saitama, Japan

Astellas Pharma Inc.

Site JP00027
Saitama, Japan

Astellas Pharma Inc.

Site JP00004
Tokyo, Japan

Astellas Pharma Inc.

Site JP00013
Tokyo, Japan

Astellas Pharma Inc.

Site JP00022
Tokyo, Japan

Astellas Pharma Inc.

Site JP00023
Tokyo, Japan

Astellas Pharma Inc.

Site JP00008
Toyama, Japan